drugset / Trial / NCT03204201

Validation of ICG to Identify the Urethra During Rectal Surgery

NCT03204201

NaSingle-groupOpen-labelOther

Summary

This is an open-label feasibility study utilising direct instillation of ICG into the urethra during surgery for low rectal cancers. The trial involves a single intervention taking place during the patient's operation. Participants will be included in the study for around 2 months with time either side of the intervention to collect background data.

Timeline

Start
2017-07-11
Primary completion
2018-07-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Other